GLP1R and Hyperglycemia: Beyond the CNS, and in another diabetes-related disorder, GLP-1 receptor agonists have shown great promise in diabetic peripheral neuropathy (DPN), a common complication of diabetes marked by nerve damage caused by chronic hyperglycemia and oxidative stress.